latest news releases from the newsroom
eLocity: Pre-Open Investor Alerts Issued For -- MBEU, SFCC, HOTT, CEPH
SARASOTA, Fla., Nov. 4, 2004 (PRIMEZONE) -- eLocity's stocks to watch for today are: Morgan Beaumont, Inc. (OTCBB:MBEU), SFBC International Inc. (Nasdaq:SFCC), Hot Topic, Inc. (Nasdaq:HOTT) and Cephalon Inc. (Nasdaq:CEPH).
China Direct Trading Corp.
China Direct Trading Corp. Sells Christmas Item to World's Largest Retailer
FORT LAUDERDALE, Fla., Nov. 4, 2004 (PRIMEZONE) -- China Direct Trading Corporation's (OTCBB:CHDT) subsidiary Souvenir Direct Inc. gets placement of its new Christmas item, Hand Bells, in the world's largest retailer (Retailer). The company has received an order from its Utah distributor for the entire state of Utah. The product will be shipped by air and placed on end caps of every store in Utah by November 15th. The product has also been chosen as the VPI product of the month for the Utah stores of the Retailer which means it was chosen as the top volume producing item from local management and competes against all other VPI items nationwide in an internal contest amongst managers. The Utah distributor will also be meeting with the Retailer's corporate buyers at the end of November 2004 to discuss placement of the Hand Bells in the entire chain for next Christmas.
Discovery Laboratories, Inc.
Discovery Makes Strategic Moves to Pioneer Medical and Commercial Opportunities of Surfactant Replacement Therapy for Neonatology
DOYLESTOWN, Pa., Nov. 4, 2004 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) has undertaken a strategic initiative to optimize the inherent medical benefits and commercial promise of its Surfactant Replacement Therapy (SRT) to address the unmet need for respiratory therapies for the Neonatal Intensive Care Unit (NICU). Discovery is today announcing the restructuring of its business arrangements with Quintiles Transnational Corp., including the mutual termination of the related commercialization arrangements. Discovery is building its own specialty pulmonary United States sales and marketing organization to focus initially on opportunities in the NICU and, as products are developed, to expand to critical care and hospital settings. This strategic initiative, led by the anticipated launch of Surfaxin(r), is intended to allow Discovery to fully control its own sales and marketing operation, establish a strong presence in the NICU, and optimize company economics.
Boliden: Recycling energy from Ronnskar's processes boosts Skelleftea Kraft's electricity stocks
STOCKHOLM, Sweden, Nov. 4, 2004 (PRIMEZONE) -- Boliden (TSE:BLS) and Skelleftea Kraft are launching a partnership project called ECOEL. A restructuring of the Ronnskar smelter's energy systems will increase the extent to which waste heat from the smelter can be converted into electricity. The increase is estimated at approximately 30 GWh per year, corresponding to the annual consumption of 1,000 average houses. Steam is delivered to Skelleftea Kraft and converted into electricity.